Predicting potent drug combinations by exploiting monotherapy resistance

Project Information

COMBAT-RES

Grant agreement ID: 950293

DOI

10.3030/950293

EC signature date 17 November 2020

Start date 1 January 2021

End date 31 December 2025

Funded under

• EXCELLENT SCIENCE - European Research Council (ERC)

Total cost

€ 1 499 991,00

EU contribution

€ 1 499 991,00

Coordinated by

HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT GMBH
Germany